Henry Skinner
Questioner · DISC type cHenry Skinner is the CEO of the AMR Action Fund, leveraging a deep background as a microbiologist, venture investor, and pharmaceutical executive to address antimicrobial resistance. His career includes leadership roles at Tekla Capital Management and Novartis Venture Fund, alongside CEO positions at biotech firms. He holds a PhD in Microbiology and an MS in Bioethics from Harvard.
Henry has a long-standing personal interest in microbiology and the history of medicine, which began during his undergraduate studies. This passion has driven his 25-year career in biotech and pharma, where he has consistently focused on developing novel antibiotics and tackling infectious diseases.
He once ran a company that focused on discovering new antibiotics by isolating them from the environment.
Read the full overview →How Henry shows up
They are more likely than others to negotiate on pricing and terms. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.
Topics Henry cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.